Treatment of glaucoma and ocular hypertension
First Claim
Patent Images
1. A compound selected from the group consisting of:
- N-(2-[4,4′
,4″
-Trichlorotrityl]oxyethyl)morpholine;
1-(2[4,4′
,4″
-Trichlorotrityl]oxyethyl)-4-(2-hydroxyethyl)piperazine dimaleate;
9-(3-Mercapto-1,2,4-trazolyl)-9-phenyl-2,7-difluorofluorenone;
1-(2-Chlorotrityl)-3,5-dimethylpyrazole;
N-(2-Chlorotrityl)-L-prolinol acetate;
1, S-Bis(4,4′
,4″
-trichlorotrityl)-1,2,4-triazole-3-thiol.
2 Assignments
0 Petitions
Accused Products
Abstract
Compositions of non-steroidal glucocorticoid antagonists for treating glaucoma or ocular hypertension and methods for their use are disclosed.
-
Citations
3 Claims
-
1. A compound selected from the group consisting of:
-
N-(2-[4,4′
,4″
-Trichlorotrityl]oxyethyl)morpholine;
1-(2[4,4′
,4″
-Trichlorotrityl]oxyethyl)-4-(2-hydroxyethyl)piperazine dimaleate;
9-(3-Mercapto-1,2,4-trazolyl)-9-phenyl-2,7-difluorofluorenone;
1-(2-Chlorotrityl)-3,5-dimethylpyrazole;
N-(2-Chlorotrityl)-L-prolinol acetate;
1, S-Bis(4,4′
,4″
-trichlorotrityl)-1,2,4-triazole-3-thiol.- View Dependent Claims (2, 3)
-
Specification